Bead-based ELISA for validation of ovarian cancer early detection markers - Wikidata - awgldk - TriplyDB

Bead-based ELISA for validation of ovarian cancer early detection markers

Bead-based ELISA for validation of ovarian cancer early detection markers

http://www.wikidata.org/entity/Q37324630

about

Beyond CA125: the coming of age of ovarian cancer biomarkers Comparison of breast cancer to healthy control tissue discovers novel markers with potential for prognosis and early detection Effects of blood collection conditions on ovarian cancer serum markers.A mouse to human search for plasma proteome changes associated with pancreatic tumor development.Systematic evaluation of candidate blood markers for detecting ovarian cancer.Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.CA125 in ovarian cancer Antifouling surface layers for improved signal-to-noise of particle-based immunoassays.HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm.Potential markers for detection and monitoring of ovarian cancer.Synthesis, characterization, and directional binding of anisotropic biohybrid microparticles for multiplexed biosensing.Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass.Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients.N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.Profiling lipid-protein interactions using nonquenched fluorescent liposomal nanovesicles and proteome microarrays Biomarker method validation in anticancer drug development Recent technical strategies to identify diagnostic biomarkers for ovarian cancer.HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care.Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer.A serum based analysis of ovarian epithelial tumorigenesis Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125.Combining a symptoms index with CA 125 to improve detection of ovarian cancer.Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA.HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors Tumor markers for early detection of ovarian cancer.Multiplexed protein detection by proximity ligation for cancer biomarker validation.Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.CMOS biosensors for in vitro diagnosis - transducing mechanisms and applications.The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis.Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.

P2860

Q24651567-00F46C08-6488-4E40-A23D-E311D016FB8D Q28748985-F28F13F1-570D-46AC-A569-7FF729AD8E75 Q33308744-51CF275D-E987-47AF-B0DB-DC06767F9E47 Q33343004-AD48C733-0818-4DD5-96BC-C0070344212D Q33350146-CBBF5C5B-CC2F-4E4B-9633-FC9B79604E15 Q33574039-C69EE57C-CE43-4912-B389-A00155079470 Q33653799-66ADC31B-2A5C-4F57-B35F-6FD74E3D4976 Q33859857-E59F2AE6-FEB0-4E4D-9094-B4A92EA89B87 Q33939569-5F56E682-52A6-4F55-B44B-06BBA64F595D Q34621826-EBF1933D-B39D-4419-8969-49C2743CD03A Q34960174-40C13F63-AE67-487F-9E39-F8C195D902A1 Q35084237-AA5B776B-A47A-41F3-8A8B-445DBD8D9B6A Q35613964-CDFE406A-F6D8-48BD-A314-9C72F3EB50B5 Q35663640-E06BE43D-8470-42F3-9296-4858351BEB1F Q35830931-D5EBEF61-352B-42C3-B6C1-CD2278380A7C Q35840714-9093FA97-2326-4546-81E3-78D58C335E01 Q35874750-4BF2A63D-02D2-49D0-BE40-BCBFF85E29D6 Q36076879-3181C431-F8CA-4E9D-B1CD-5588EAFE63A5 Q36226142-16128C45-1547-4D35-AB37-756DA6B05B17 Q36386960-4A7B8454-7D38-43E9-8990-1C95828BF4F5 Q36484621-00AAD299-2FD7-4637-9C64-8743909F44B3 Q36731399-EA249D0E-7544-4108-826B-EC96833F5D24 Q36790307-7C92E384-24E2-42AD-8147-D46EB82C98B9 Q36915914-EDCD49C2-0AAC-4C75-B142-4107C7721653 Q37076713-2393847E-EAF3-448C-82DB-E1FDBC9BE150 Q37133800-B001618F-CC5E-4B2E-89C2-83357ABBC375 Q37270601-B0DA4AC1-890D-48BE-949D-DE0F58E5FFAB Q37324647-9E308E5B-8BCF-476A-A3E0-760E9FAD6FDE Q37340624-8C115447-8C03-4E39-936F-8540BC7075F1 Q37348306-13FD4541-30B6-42FB-AD9D-9819094824AD Q37375504-A5D08857-D0B7-4ABD-8033-F3AD3A39F3E6 Q37643626-F0DE3FCF-7138-4A14-90F8-0D80303A64D1 Q37789033-1B7EEAC7-D2EE-468C-B886-7D5DF5F00759 Q38398465-BA630700-DCC6-4593-9647-C2B32A56F356 Q38470014-08693F36-5613-4DE5-B7D0-7D6723D9FB11 Q38974546-13D29199-44A2-4B53-923C-D2D64C1D533C Q39437253-B4DE74D7-131D-48D0-B014-F3E537469547 Q40428099-C82DA192-70D1-40D1-A995-0A66D118C16D Q43728520-02AC1036-94D9-4FD7-AC9C-2D2DCDBF7730 Q43799326-70A728B8-EF71-4055-B6EE-4A4924CF0E73

P2860

Bead-based ELISA for validation of ovarian cancer early detection markers

http://www.wikidata.org/entity/Q37324630

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bead-based ELISA for validation of ovarian cancer early detection markers

@en

Bead-based ELISA for validation of ovarian cancer early detection markers.

@nl

type

label

Bead-based ELISA for validation of ovarian cancer early detection markers

@en

Bead-based ELISA for validation of ovarian cancer early detection markers.

@nl

prefLabel

Bead-based ELISA for validation of ovarian cancer early detection markers

@en

Bead-based ELISA for validation of ovarian cancer early detection markers.

@nl

P1433

Q37324630-7A641185-DCFF-48BC-B808-4C5DE3F9DB60

P1476

Q37324630-AB5902CF-78E6-4A3A-B35D-00A51C1D0F44

P2093

Q37324630-39DF1E47-81A6-40ED-93E9-E3BD6E1DE22D

Q37324630-650DAB20-0B82-465A-819F-2BDA356EB8AA

Q37324630-6E28B754-7218-4BDF-AD12-A1691758FB9B

Q37324630-983F2130-D925-41B5-AC9A-DAF3AB362C23

Q37324630-A72F7AFE-8467-4671-8597-C4AC0A9E610A

Q37324630-CA50F884-FD8F-40A1-834B-8776C940E94E

Q37324630-DA14DDF4-E84B-4B43-8A78-BD4D2C4ED51D

P2860

Q37324630-076D6727-175A-48A3-BEE7-268AF59A5098

Q37324630-08196319-98C9-40F6-8A2A-C0870732092A

Q37324630-0BD4FD74-9DA9-43A4-8067-B17BDD4CE2B6

Q37324630-10622887-7102-41C0-8019-183C0514BADE

Q37324630-137BFE6A-378C-4BCE-A480-E662CB692538

Q37324630-1E82BFDE-CDA4-4739-8D83-14036650CE75

Q37324630-1EF62ED0-4DEB-47AE-805E-F90C46332E90

Q37324630-1F25E413-426F-45AF-B1DB-6B5FA4FCC9A8

Q37324630-2F475166-4EB4-4924-B233-08B4DEEAE784

Q37324630-420352F8-EE6C-4EDA-BEBF-888123ED37B4

P304

Q37324630-5E82446F-9289-41ED-8818-81E17837A049

P31

Q37324630-13193641-912A-4C77-93E1-CC51D111905A

P356

Q37324630-A030385D-2183-40F5-8E57-2C7198AE5EC0

P407

Q37324630-9B87201C-6D7F-4C5D-9393-A973BEE271D7

P433

Q37324630-D3058C36-914F-4783-82ED-730B79B94BAA

P478

Q37324630-9630F4CE-A2F9-4EB7-A324-B1D2674C6DB8

P50

Q37324630-6D99BDFB-E3F2-4FD8-BBCC-6FDDEA5A35C4

P577

Q37324630-6B9D32F2-7B9B-4B76-8FEE-2235CEAC4B3C

P698

Q37324630-4107E7A0-4B74-4102-B72C-73D7A512AA82

P921

Q37324630-BE26B9EB-A280-4893-8767-4B8D9FB9E9B9

P932

Q37324630-9CF673BA-6900-498A-A501-58A595DB1958

P356

1078-0432.CCR-05-2007

P1433

Clinical Cancer Research

P1476

Bead-based ELISA for validation of ovarian cancer early detection markers

@en

P2093

Alicia Sato

http://www.w3.org/2001/XMLSchema#string

Charles W Drescher

http://www.w3.org/2001/XMLSchema#string

Garnet L Anderson

http://www.w3.org/2001/XMLSchema#string

Kathy C O'Briant

http://www.w3.org/2001/XMLSchema#string

Meghan Crawford

http://www.w3.org/2001/XMLSchema#string

Nancy Kiviat

http://www.w3.org/2001/XMLSchema#string

Nicole Urban

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Reactivity of a monoclonal antibody with human ovarian carcinoma

The role of CA125 in clinical practice

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Multiplexed particle-based flow cytometric assays.

Progress and challenges in screening for early detection of ovarian cancer.

Screening postmenopausal women for ovarian cancer: a systematic review.

CA 125: the past and the future.

Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.

P304

2117-2124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-2007

http://www.w3.org/2001/XMLSchema#string

P407

P433

7 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Nathalie Scholler

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16609024

http://www.w3.org/2001/XMLSchema#string

P921

P932

2734269

http://www.w3.org/2001/XMLSchema#string